- Doctor en Medicina "cum laude" por la Universidad de San Pablo CEU con el estudio "Implementación de un programa de medicina personalizada en el cáncer de páncreas" dirigida pro el prof. Manuel Hidalgo. Co-investigador en mas de 40 ensayos clínicos en los últimos 5 años (Fases 0, 1, 2 y 3)
1. Isolated recurrence of disal adenocarcinoma of the extrahepatic bile duct on a draining sinus scar after curative resection: case report and review of the literature. Rodriguez-Pascual J, De Vicente E, Quijano Y, Pérez-Rodríguez F, Bergaz F, Hidalgo M, Duran I. World J Surg Oncol 2009 Dec 14:7;96.
2. Emergent toxicities associated with the use of mTOR inhibitors in patients with advanced renal carcinoma. Rodriguez-Pascual J, Cheng E, Maroto P, Duran I. Anticancer Drugs 2010 Jun 21(5):478-86. Review.
3. Epidermal Growth Factor Receptor as a Target in Pancreatic Cancer. A Cubillo Gracian, J Rodríguez Pascual, M Hidalgo Medina. Cancer & Chemotherapy Rev 2008;4:224-30
4. A preclinical and clinical study of mycophenolate mofetil in pancreatic cancer. Rodríguez-Pascual J, Sha P, García-García E, Rajeshkumar NV, De Vicente E, Quijano Y, Cubillo A, Angulo B, Hernando O, Hidalgo M. Invest New Drugs. 2013 Feb;31(1):14-9
5. A Prospective Pilot Study of Target-guided Personalized Chemotherapy with Intensity-modulated Radiotherapy in Patients With Early Rectal Cancer. Cubillo A, Hernando-Requejo O, García-García E, Rodriguez-Pascual J, De Vicente E, Morelli P, Rubio C, López-Ríos F, Muro A, López U, Prados S, Quijano Y, Hidalgo M. Am J Clin Oncol. 2012 Dec 1.
6. Stromal disrupting effects of nab-paclitaxel in pancreatic cancer. Alvarez R, Musteanu M, Garcia-Garcia E, Lopez-Casas PP, Megias D, Guerra C, Muñoz M, Quijano Y, Cubillo A, Rodriguez-Pascual J, Plaza C, de Vicente E, Prados S, Tabernero S, Barbacid M, Lopez-Rios F, Hidalgo M. Br J Cancer. 2013 Aug 20;109(4):926-33
7. Phase II Trial of Target-guided Personalized Chemotherapy in First-line Metastatic Colorectal Cancer. Cubillo A, Rodriguez-Pascual J, López-Ríos F, Plaza C, García E, Alvarez R, de Vicente E, Quijano Y, Hernando O, Rubio C, Perea S, Sanchez G, Hidalgo M. Am J Clin Oncol. 2014 Feb 10
8. Reply: 'Comments on Stromal disrupting effects of nab-paclitaxel in pancreatic cancer'. Alvarez R, Musteanu M, Garcia-Garcia E, Lopez-Casas PP, Megias D, Guerra C, Muñoz M, Quijano Y, Cubillo A, Rodriguez-Pascual J, Plaza C, de Vicente E, Prados S, Tabernero S, Barbacid M, Lopez-Rios F, Hidalgo M. Br J Cancer. 2014 Mar 18.
9. Complete pathological responses in locally advanced rectal cancer after preoperative IMRT and integrated-boost chemoradiation. Hernando-Requejo O, López M, Cubillo A, Rodriguez A, Ciervide R, Valero J, Sánchez E, Garcia-Aranda M, Rodriguez J, Potdevin G, Rubio C. Strahlenther Onkol 2014 Apr 9.
